Supplemental material
Cell Cycle
Volume 12, 2013 - Issue 24
Related Research Data
Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena.
Source:
Informa UK Limited
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Source:
Proceedings of the National Academy of Sciences
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Source:
American Association for Cancer Research (AACR)
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Source:
Springer Science and Business Media LLC
A Systematic Review and Meta-analysis
Source:
American Medical Association (AMA)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Source:
American Association for the Advancement of Science (AAAS)
Metformin as an adjuvant in breast cancer treatment.
Source:
SAGE Publications
Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence.
Source:
Georg Thieme Verlag KG
Causes and Consequences of Increased Glucose Metabolism of Cancers
Source:
Society of Nuclear Medicine
Metformin in Breast Cancer: Time for Action
Source:
American Society of Clinical Oncology (ASCO)
Glucose metabolism and cancer.
Source:
Elsevier BV
Host-Related Factors in Breast Cancer: An Underappreciated Piece of the Puzzle?
Source:
American Society of Clinical Oncology (ASCO)
The Warburg Effect returns to the cancer stage.
Source:
Elsevier BV
Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.
Source:
Springer Science and Business Media LLC
Doctors Seek To Prevent Breast Cancer Recurrence by Lowering Insulin Levels
Source:
Oxford University Press (OUP)
Upper abdominal obesity, insulin resistance and breast cancer risk.
Source:
Springer Science and Business Media LLC
Metformin and cancer: new applications for an old drug
Source:
Springer Science and Business Media LLC
Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.
Source:
Informa UK Limited
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Source:
Informa UK Limited
Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.
Source:
The Endocrine Society
Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells.
Source:
Springer Science and Business Media LLC
New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
Source:
American Diabetes Association
Targeting glucose metabolism for cancer therapy
Source:
Rockefeller University Press
Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission
Source:
American Association for Cancer Research (AACR)
Metformin-Induced Killing of Triple Negative Breast Cancer Cells is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b
Source:
Springer Science and Business Media LLC
Insulin in the Adjuvant Breast Cancer Setting: A Novel Therapeutic Target for Lifestyle and Pharmacologic Interventions?
Source:
American Society of Clinical Oncology (ASCO)
Investigating the Inhibitory Aspects of Metformin/Curcumin Co-Treatment through Convergence of In-Silico and In-Vitro Approaches
Source:
bioRxiv
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
Source:
BioMed Central
Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells
Source:
American Association for Cancer Research (AACR)
Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification
Source:
Springer Science and Business Media LLC
Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
Source:
Informa UK Limited
Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors.
Source:
Bentham Science Publishers Ltd.
Tumor Cell Metabolism: Cancer's Achilles' Heel
Source:
Elsevier BV
Metformin, cancer and glucose metabolism
Source:
Bioscientifica
Sugar and fat – that's where it's at: metabolic changes in tumors
Source:
Springer Science and Business Media LLC
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Source:
American Society of Clinical Oncology (ASCO)
Linking provided by
